I was still disappointed.
Sure, this was good news with some good probability numbers on a small number of trial participants.
But some things make me nervous:
- Only five trial participants, and it was open label. This might mean that the results aren't particularly meaningful (though the low p scores somewhat make up for it)
- They decided to report this instead of the two trials they were actually supposed to have some results for by the end of June (PMLE phase III interims and PDT phase II)
positive news, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.92 |
Change
-0.030(0.20%) |
Mkt cap ! $747.1M | |||
| Open | High | Low | Value | Volume |
| $14.91 | $15.19 | $14.71 | $936.9K | 62.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 167 | $14.92 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.00 | 57 | 1 |
View Market Depth
| Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |